Breaking News

AcuraBio Expands cGMP Plasmid DNA, CDMO Services with Cytiva’s Single-Use Purification Technology

The new protocol features single-use purification technology which aims to deliver efficiency, high purity level outcome and sustainable process.

AcuraBio, a biopharmaceutical contract development and manufacturing organization (CDMO), will provide a cGMP plasmid DNA CDMO service using Cytiva’s new process platform technology.  AcuraBio expects to produce more plasmid DNA for its customers around the world using Cytiva’s latest bacterial plasmid two-step purification protocol. The new protocol features single-use purification technology which delivers efficiency, high purity level outcome and sustainable process. Guillau...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters